Risks of leukaemia and solid tumours in individuals with Down's syndrome
Top Cited Papers
- 1 January 2000
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 355 (9199) , 165-169
- https://doi.org/10.1016/s0140-6736(99)05264-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Overexpression of copper-zinc superoxide dismutase in trisomy 21Cellular and Molecular Life Sciences, 1996
- Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroNature, 1995
- Clonal Hematologic Disorders in Down Syndrome A ReviewJournal of Pediatric Hematology/Oncology, 1995
- Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”)Medical and Pediatric Oncology, 1993
- SOD2: A new type of tumor‐suppressor gene?International Journal of Cancer, 1992
- Down's Syndrome—Transient Abnormal Myelopoiesis and Acute LeukaemiaLeukemia & Lymphoma, 1991
- Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study GroupThe Journal of Pediatrics, 1984
- Mortality and cause of death in Down's syndrome.Journal of Epidemiology and Community Health, 1982
- Plasma lipids and lipoproteins in Down's syndromeScandinavian Journal of Clinical and Laboratory Investigation, 1979
- MORTALITY AND LIFE‐TABLE IN DOWN'S SYNDROMEActa Paediatrica, 1975